Burong, Ramser O.
HRN: 17-96-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/17/2023
01/24/2023
IV
150mg
Q24h
T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes